F. Gurlek and E. Tasdemir, “Is it an advantage or disadvantage to usage angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in COVID-19 patients?”, Int J Res Med Sci, vol. 8, no. 12, pp. 4200–4205, Nov. 2020.